Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenesis and ophthalmic disease.

A P Adamis1, L P Aiello, R A D'Amato

  • 1Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA.

Angiogenesis
|October 1, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of diabetes and diabetes type on anatomic and visual outcomes following central rein vein occlusion.

Eye (London, England)·2014
Same author

Regression activity that is naturally present in vitreous becomes ineffective as patients develop proliferative diabetic retinopathy.

Diabetologia·2013
Same author

Possible contribution of hyalocytes to idiopathic epiretinal membrane formation and its contraction.

The British journal of ophthalmology·2009
Same author

Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy.

Eye (London, England)·2008
Same author

Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial.

The British journal of ophthalmology·2008
Same author

Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study.

Ophthalmology·2007
Same journal

Endothelial Notch1 drives multicellular remodelling during hyaloid vessel regression.

Angiogenesis·2026
Same journal

Endothelial protein C receptor and the endothelial progenitor paradigm: towards a functional definition at last.

Angiogenesis·2026
Same journal

Tumour endothelial cell reprogramming orchestrates angiocrine signalling to drive chemoresistance in breast cancer.

Angiogenesis·2026
Same journal

A possible microvascular vulnerability in carotid artery dissection: insights from nailfold capillaroscopy.

Angiogenesis·2026
Same journal

miR-150 controls developmental angiogenesis via ribosome biogenesis-dependent regulation of Notch signaling.

Angiogenesis·2026
Same journal

MCC links Wnt/PCP signaling to endothelial polarity and vascular remodeling.

Angiogenesis·2026
See all related articles

Ocular angiogenesis, the development of new blood vessels in the eye, causes irreversible blindness globally. This review summarizes key diseases and pathogenesis of pathological ocular neovascularization.

Area of Science:

  • Ophthalmology
  • Vascular Biology
  • Pathology

Background:

  • Ocular angiogenesis is a major cause of irreversible blindness worldwide.
  • It is implicated in diverse diseases including trachoma, retinopathy of prematurity, diabetic retinopathy, neovascular glaucoma, and age-related macular degeneration.
  • Pathological new vessel growth in the eye is termed neovascularization, synonymous with angiogenesis in this context.

Purpose of the Study:

  • To review the clinical and laboratory findings of epidemiologically significant diseases characterized by ocular angiogenesis.
  • To summarize current understanding of the pathogenesis of ocular angiogenesis.
  • To provide a comprehensive overview of pathological neovascularization in the eye.

Main Methods:

  • Literature review of clinical and laboratory findings.

Related Experiment Videos

  • Synthesis of current concepts on the pathogenesis of ocular angiogenesis.
  • Focus on epidemiologically significant ocular diseases.

    • Main Results:

    • Ocular angiogenesis is a common pathway in several leading causes of blindness.
    • Understanding the pathogenesis is crucial for developing therapeutic strategies.
    • Neovascularization underlies conditions affecting all age groups.

    Conclusions:

    • Ocular angiogenesis represents a significant global health challenge, leading to irreversible vision loss.
    • Further research into the pathogenesis of neovascularization is essential for effective treatment and prevention.
    • Comprehensive knowledge of associated diseases is key to managing ocular angiogenesis.